As of Jul 22 2014 4:00PM
Minimum 20 minute delay
  • 7/22/2014 7:01:00 AM

    Covidien Announces Leadership Appointment

    DUBLIN, Ireland--(BUSINESS WIRE)--Jul. 22, 2014-- Covidien plc (NYSE: COV) today announced that Bryan Hanson, who currently serves as group president, Medical Devices & U.S., will be elevated to the newly created position of group president, Covidien, effective Oct. 1…
  • 7/16/2014 4:05:00 PM

    Covidien Declares Quarterly Cash Dividend

    DUBLIN, Ireland--(BUSINESS WIRE)--Jul. 16, 2014-- Covidien plc (NYSE: COV) today announced that its Board of Directors has declared a quarterly cash dividend of $0.32 per ordinary share. The dividend is payable on August 19, 2014, to shareholders of record on July 29, 2014…
  • 7/16/2014 7:27:00 AM

    Covidien Makes Liver Tumor Ablation More Predictable

    Emprint™ Ablation System enables more certainty regardless of target location or tissue type DUBLIN, Ireland--(BUSINESS WIRE)--Jul. 16, 2014-- Overcoming a significant roadblock to predictable ablation of soft tissue, Covidien plc (NYSE:COV) has unveiled an advanced ablation system that offers physicians predictable results regardless of the target l…

A Partner in Health

Collaborating with physicians and other healthcare professionals, focusing on research and development and maintaining clinical leadership add up to innovative medical solutions that make a difference.

Conscientious Collaboration

Ensuring ethical interactions with healthcare professionals is vital to the global healthcare environment. Covidien’s Conscientious Collaboration platform is our commitment to open communications about the need to ensure compliant interactions with our customers and partners.

One Covidien

One look. One Covidien. Experience the new unified look of Covidien. Easy-to-use labeling. New outside packaging with the same quality products inside. First-class service and support.

Visit Us